Conversion Ratio. The “Conversion Ratio” for each share of Series A Non-Voting Preferred Stock shall be 1,000 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1), subject to adjustment as provided herein.
Appears in 5 contracts
Samples: Merger Agreement (Aerovate Therapeutics, Inc.), Merger Agreement (Spyre Therapeutics, Inc.), Merger Agreement (Aeglea BioTherapeutics, Inc.)
Conversion Ratio. The “Conversion Ratio” for each share of Series A Non-Voting Preferred Stock shall be 1,000 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1), subject to adjustment as provided herein.
Appears in 1 contract
Conversion Ratio. The “Conversion Ratio” for each share of Series A Z Non-Voting Preferred Stock shall be 1,000 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A Z Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1), subject to adjustment as provided herein.
Appears in 1 contract
Conversion Ratio. The “Conversion Ratio” for each share of Series A X Non-Voting Preferred Stock shall be 1,000 [1,000] shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A X Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1), subject to adjustment as provided herein.
Appears in 1 contract
Samples: Merger Agreement (Baudax Bio, Inc.)
Conversion Ratio. The “Conversion Ratio” for each share of Series A C Non-Voting Preferred Stock shall be 1,000 10,000 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A C Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1)Stock, subject to adjustment as provided herein.
Appears in 1 contract
Conversion Ratio. The “Conversion Ratio” for each share of Series A Non-Voting Preferred Stock shall be 1,000 10 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A Non-Voting Preferred Stock (corresponding to a ratio of 1,000:110:1), subject to adjustment as provided herein.
Appears in 1 contract
Conversion Ratio. The “Conversion Ratio” for each share of Series A Non-Non- Voting Preferred Stock shall be 1,000 shares of Common Stock issuable upon the conversion (the “Conversion”) of each share of Series A Non-Voting Preferred Stock (corresponding to a ratio of 1,000:1), subject to adjustment as provided herein.
Appears in 1 contract